Updated on
An Italian mid-market board faces the choice. Capital injection needed: EUR 8M for growth investment. On the table: existing shareholders’ capital increase (dilution among current shareholders), or company sale to strategic acquirer (full exit at premium). The board chooses capital increase. Eighteen months later, the investment underperforms, the dilution is consolidated, and the original buyer who offered EUR 35M EV is now a competitor accelerated by capital that wasn’t there before.
Italian boards systematically choose capital increase over sale in scenarios where economic analysis would suggest the inverse. The pattern is recurring, identifiable, and rarely discussed openly. Here are the reasons — and the methodological question that boards should ask before deciding.
The thesis
Capital increase versus sale is presented as a financial choice. It is, primarily, an identity and political choice. The financial dimension provides rhetorical cover for decisions actually driven by other factors. Recognising this dimension allows boards to make better decisions — even when the final choice remains capital increase.
Situation 1 — The founder does not want to “lose his work”
For founders, sale represents identity transition. Forty years of work translates into shares of a buyer fund. Even at full multiples, the founder feels he has “lost” something. Capital increase, even if economically suboptimal, preserves the title of founder, the role in the company, the social positioning in the local community.
Boards respect this dynamic — and often endorse capital increase as compromise that “saves” the founder. The cost is the value destruction post-decision: 25-40% of enterprise value typically lost when capital increase replaces well-priced sale.
Situation 2 — Family-appointed directors have interests aligned with status quo
In family-controlled boards, several directors are family members or appointed by the family. Their economic interest: continuation of family control, preservation of management contracts, maintained employment status. Sale ends these benefits; capital increase preserves them.
The board votes on the proposal ignoring the conflict. The conflict is structural and would require disclosure under serious governance standards. Italian mid-market governance often does not document this — producing decisions that fail economic optimisation.
Situation 3 — Fear of post-sale market judgment
For executive directors, sale to strategic buyer means their work is “judged” by the buyer’s organisation. Mistakes become visible, processes are compared to industry best practice, individual contributions are evaluated. Capital increase preserves the autonomy that allows mistakes to remain internal.
This dynamic produces preference for capital increase even when economic analysis suggests sale would generate 30-50% higher value for shareholders.
Situation 4 — The illusion that fresh capital solves underlying problems
Capital increase is often proposed as “solution” to symptoms — declining margins, lost customers, competitive intensification. The implicit assumption: more capital will reverse these dynamics through investment in marketing, technology, capacity. Empirical evidence: 50-70% of capital increases targeting underlying market problems fail to reverse the trajectory. The capital is consumed in 18-36 months without structural change, and the original problem persists alongside increased dilution.
The methodological question to ask in the board
Before voting on capital increase versus sale, a serious board should answer six questions explicitly:
- What is the realistic enterprise value range with current standalone business?
- What is the realistic enterprise value range post-capital-increase with successful execution?
- What is the realistic enterprise value range post-capital-increase with mediocre execution?
- Is the strategic acquirer’s offer above the standalone median range?
- What probability do we assign to successful execution of the capital-increase plan?
- Adjusting expected post-capital-increase value for execution probability, does it exceed the immediate sale value?
Explicit answers — written, documented, signed by board members — change the dynamic. When directors must articulate explicit probability assessments, the cognitive biases that drive default capital-increase decisions become harder to sustain.
Conclusion
The capital-increase versus sale decision is rarely a pure financial calculation. It involves identity preservation, political alignment, fear of judgment, illusion of capital-as-solution. Boards making explicit the non-financial dimensions of this decision often arrive at different conclusions than boards that treat it as financial-only.
For founders, executive directors, and board members facing this decision: the methodological question matters more than the answer. Asking the right question structurally improves decision quality. The answer remains your judgement — informed by analysis rather than driven by unexamined assumptions.
Frequently asked questions
When is capital increase really the better option?
When the standalone trajectory is genuinely strong, the strategic premium of sale is modest, and post-capital-increase execution probability is high. Pattern: capital increase optimal in growth phases with clear execution roadmap; sub-optimal in defensive scenarios where capital is sought to address competitive pressure.
Is opening minority capital to a partner a third way?
Sometimes yes. When founder wants liquidity for partial exit while continuing operationally, growth PE with minority stake can be optimal. Requires PE partner accepting non-control — rare in classic PE, more common in family offices and industrial partners.
How to measure if a capital increase has “worked”?
Standard metrics: enterprise value 36 months post-increase vs pre-increase standalone projection. Pattern: successful capital increase produces 1.5-2x enterprise value vs original; underperforming produces 0.8-1.2x. Honest post-mortem critical for organisational learning.
Can management honestly propose the sale?
Difficult but essential. Senior management often has interests aligned with continued employment (against sale) but professional duty to recommend value-maximising path. Pattern: best management teams declare conflict explicitly while providing balanced recommendation. Worst teams advocate continuation as default without serious evaluation of alternatives.
Facing capital increase versus sale decision?
30-minute discovery call to discuss your specific board situation in confidential setting. Confidential conversation →


